Spire Healthcare Group (LON:SPI – Get Free Report) issued its quarterly earnings results on Wednesday. The company reported GBX (0.50) earnings per share (EPS) for the quarter, Digital Look Earnings reports. Spire Healthcare Group had a return on equity of 2.22% and a net margin of 1.04%.
Spire Healthcare Group Price Performance
Spire Healthcare Group stock traded up GBX 1 during midday trading on Thursday, reaching GBX 247.50. 71,514,227 shares of the stock traded hands, compared to its average volume of 5,796,127. The stock has a market cap of £991.48 million, a P/E ratio of 61.88, a PEG ratio of 1.06 and a beta of 0.93. The stock’s fifty day moving average is GBX 238.06 and its 200-day moving average is GBX 207.59. The company has a quick ratio of 0.73, a current ratio of 0.63 and a debt-to-equity ratio of 177.14. Spire Healthcare Group has a 12 month low of GBX 140.80 and a 12 month high of GBX 249.
Analyst Upgrades and Downgrades
Separately, Royal Bank Of Canada lowered Spire Healthcare Group to a “sector perform” rating and dropped their price objective for the stock from GBX 300 to GBX 250 in a research note on Monday, September 7th. One research analyst has rated the stock with a Buy rating and one has assigned a Hold rating to the stock. Based on data from MarketBeat.com, Spire Healthcare Group presently has an average rating of “Moderate Buy” and an average target price of GBX 247.50.
Spire Healthcare Group Company Profile
Spire Healthcare Group plc, together with its subsidiaries, owns and operates private hospitals and clinics. It offers various treatments in the areas of allergy and infectious diseases, blood tests, bones and joints, bowel treatments, breast screening and surgery, cancer investigations and treatments, cosmetic surgery, cyst removal, and dental surgery, as well as ear, nose, and throat treatments. The company also provides eye surgery and treatments, family planning, gastroenterology, general medicine, general surgery, haematology, hand surgery, hip and knee treatment, and heart and kidney treatments.
See Also
- Five stocks we like better than Spire Healthcare Group
- Everyone in AI Is Quietly Copying Palantir’s Playbook
- Advanced Micro Devices Is Spending $8.2 Billion to Learn What AI Needs Next
- JPMorgan Bets on Genius Sports as the Market Loses Patience
- Apple’s $5.7 Billion Patent Verdict Raises a Bigger Royalty Question
Receive News & Ratings for Spire Healthcare Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Spire Healthcare Group and related companies with MarketBeat.com's FREE daily email newsletter.
